Clinical Trial Update: A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED) [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study in healthy adults comparing three formulations of ondansetron for prevention of chemotherapy-induced nausea and vomiting; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 1 | Status: COMPLETED | Results posted: 2010-08-26